Pimavanserin Pharmacology Podcast
Real Life Pharmacology - Pharmacology Education for Health Care Professionals
Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist
4.9 • 773 Ratings
🗓️ 1 January 2026
⏱️ 13 minutes
🧾️ Download transcript
Summary
Pimavanserin is an atypical antipsychotic approved for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. Unlike traditional antipsychotics, it does not block dopamine receptors, making it a unique option for patients with Parkinson’s disease who are highly sensitive to dopamine antagonism.
Mechanism of Action
Pimavanserin works primarily as a selective serotonin 5-HT2A inverse agonist and antagonist, with minor activity at 5-HT2C receptors. This dopamine-sparing effect is the key reason it does not worsen motor symptoms in Parkinson’s disease.
Adverse Effects
The most commonly reported side effects include peripheral edema, nausea, confusion, and hallucinations. QT interval prolongation is a clinically important concern, especially in patients with existing cardiac risk factors. Somnolence may occur but is generally less prominent compared with dopamine-blocking antipsychotics.
Warnings and Precautions
Pimavanserin carries a boxed warning for increased mortality in elderly patients with dementia-related psychosis, consistent with other antipsychotics. It should not be used in patients with known QT prolongation, a history of ventricular arrhythmias, or in combination with other QT-prolonging agents when possible.
Drug Interactions
Strong CYP3A4 inhibitors, such as ketoconazole or clarithromycin, can significantly increase pimavanserin concentrations and require dose reduction. Strong CYP3A4 inducers, such as rifampin or carbamazepine, may reduce efficacy and should generally be avoided. Additive QT prolongation may occur when combined with other QT-prolonging medications, including certain antiarrhythmics, fluoroquinolones, and macrolide antibiotics.
Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE!
Support The Podcast and Check Out These Amazing Resources!
Meded101 Guide to Nursing Pharmacology (Amazon Highly Rated)
Guide to Drug Food Interactions (Amazon Best Seller)
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Hey all, welcome back to the Real Life Pharmacology podcast. I'm your host, pharmacist, Eric Christensen. |
| 0:05.9 | Thank you so much for listening today. The drug of the day is going to be Pimavansurin. |
| 0:12.2 | Brand name is Newplazid. Before we get into it, reminder, go check out real life pharmacology.com. |
| 0:20.4 | We've got a list, 31 page PDF, absolutely free to you. |
| 0:24.8 | Simply an email will get you access to that. |
| 0:27.8 | Tons of great reminders, clinical practice pearls, |
| 0:30.8 | as well as things that show up on board exams |
| 0:33.7 | and pharmacology exams throughout your career too. |
| 0:36.1 | So definitely a no-brainer. Go snag |
| 0:38.9 | that at real-life pharmacology.com. All right, let's get into Pimavanserin brand name New |
| 0:46.6 | Placid. This is an antipsychotic. It would be considered an atypical antipsychotic. |
| 1:02.1 | This medication is approved for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. |
| 1:07.0 | That is its specific indication and the likelihood you see it for something else is |
| 1:13.5 | pretty unlikely at this point because it's actually very very expensive now it differs |
| 1:20.7 | pretty significantly from traditional antipsychotics in that it really doesn't block dopamine receptors at all. |
| 1:29.9 | So that makes it unique in Parkinson's disease because drugs that block dopamine can |
| 1:39.2 | worsen Parkinson's symptoms, or at least they're highly sensitive to dopamine blockade. |
| 1:47.6 | So if it doesn't work by dopamine blockade, how does it work? |
| 1:51.9 | So Pimavanseran works primarily as a selective serotonin 5H2A inverse ag inverse agonist, and antagonist. |
| 2:02.8 | It also has some minor activity at 5HT2C receptors as well. |
| 2:09.8 | So ultimately this helps alleviate psychotic symptoms without messing up that dopamine pathway that needs to be preserved in |
| 2:22.2 | Parkinson's disease to obviously help allow people to better function and move. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.